Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response (Q46448105)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
scientific article

    Statements

    Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit